M

Mey Capital Matrix GmbH

0 employees

The MEY Capital Matrix GmbH is a company which helps to reduce healthcare cost and provides personalized medicines.

Investor insights

Sectors invested in

Biotechnology6

Health Care6

Medical4

Therapeutics2

Molecular Diagnostics2

Nanotechnology2

Molecular Technology2

Nucleic Acid Amplification2

Health Diagnostics2

OEM2

Life Sciences2

Biosecurity2

Laser PCR2

Food Safety2

Molecular Assays2

Laboratory Equipment2

Optoacoustic Imaging2

Molecular Imaging2

Medical Devices2

Diagnostic Imaging2

Funding rounds participated in

$6.6M sweet spot round size

Most of their 7 investments are in rounds between $2M and $14M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Date founded

2010

Investments made

P

Pumpkin Organics GmbH raised $4.3M on May 17, 2023

Investors: Feast Ventures and Mey Capital Matrix GmbH

i

iThera Medical GmbH raised $14M on December 21, 2022

Investors: FLUXUNIT / ams-OSRAM Ventures, StMWi, OCCIDENT, TRUMPF Venture, BayBG VENTURE CAPITAL and Mey Capital Matrix GmbH

G

GNA Biosolutions GmbH raised $14M on August 6, 2019

Investors: b-to-v Partners AG, UVC Partners, Robert Bosch Venture Capital GmbH (RBVC), StMWi, OCCIDENT, KfW, SHS Capital and Mey Capital Matrix GmbH

G

GNA Biosolutions GmbH raised $6.6M on March 7, 2015

Investors: UVC Partners, SHS Capital, b-to-v Partners AG, KfW, Robert Bosch Venture Capital GmbH (RBVC) and Mey Capital Matrix GmbH

c

conoGenetix biosciences GmbH raised $2M on April 23, 2012

Investors: Mey Capital Matrix GmbH

i

iThera Medical GmbH raised undisclosed on November 23, 2011

Investors: BayBG VENTURE CAPITAL and Mey Capital Matrix GmbH

S

Soluventis GmbH raised undisclosed on February 1, 2011